Although I completely respect and support your decision Ryan, my heart still breaks because it seems like you were so close. I do think your story mirrors many out there. It really shouldn’t be as difficult as it has been for you to access this treatment. My fear is that now that there’s a treatment available maybe the urgency for other treatments to come to market just isn’t there. Hopefully I’m wrong and the market will soon be flooded with treatment options.
I’m looking forward to new treatments that are easier and/or less frequent to administer. I’m hopeful that there’s continued urgency due to: (1) a clear market evidenced by Biogen’s success, but even more so (2) regulators & payers are likely desperate for competition to combat Spinraza’s notoriously huge price tag and infrastructure necessary for administration.
SMA News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.